Powered by

PerkinElmer's Non-Invasive Saliva-Based Testing Gets CE Mark

Nov 16, 2020 - Nasdaq

PerkinElmer, Inc. PKI recently announced that its SARS-CoV-2 Real-time RT-PCR (reverse transcription-polymerase chain reaction) Assay received CE-IVD marking for the utilization of saliva as specimen type and the choice to combine up to five specimens from suspected COVID-19 infected or asymptomatic individuals.

Notably, the laboratories in countries where CE mark is recognized will now have the option of accepting saliva specimens and implement sample pooling utilizing PerkinElmer SARS-Co...